• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TORAX MEDICAL, INC. 1.5T LINX, 15B; ANTI-REFLUX IMPLANT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TORAX MEDICAL, INC. 1.5T LINX, 15B; ANTI-REFLUX IMPLANT Back to Search Results
Model Number LXMC15
Device Problem Patient Device Interaction Problem (4001)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 02/11/2020
Event Type  malfunction  
Manufacturer Narrative
(b)(4).The dhr for lot 23772 was reviewed.No ncs, defects, or reworks related to the product complaint were found if information is obtained that was not available for the initial report, a follow-up report will be field as appropriate.
 
Event Description
The following was reported that the patient had ongoing diarrhea.Start date: (b)(6) 2020 (new onset 21 days after the linx implant).It may be related to irritation of the vagus nerve stimulating the gastrocolic reflex or it could be related to stopping high dose ppis, which this patient was on for 20 years.The patient is experiencing dysphagia after eating.The patient has not been eating as much due to the diarrhea.The diarrhea has improved so patient is eating more and experiencing intermittent dysphagia.Patient will start eating small amounts every two hours.Medrol dose pack started.There are no plans to explant the device.The patient is very pleased with her results.
 
Manufacturer Narrative
(b)(4).Date sent: 01/08/2021.Additional information received: presumed candidal esophagitis discovered during egd.Pt.Reported no symptoms.Pt.Was recently on a course of antibiotics which may be the cause.
 
Manufacturer Narrative
(b)(4), date sent: 3/22/2021.Additional information received: date of resolution: 29 dec 2020 resolution of candidal esophagitis.
 
Manufacturer Narrative
(b)(4), date sent: 2/11/2021.Additional information received: the patient was prescribed diflucan-200 mg.Po, qd, (b)(6) 2020 through (b)(6) 2020.Pathology confirmed candidal esophagitis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
1.5T LINX, 15B
Type of Device
ANTI-REFLUX IMPLANT
Manufacturer (Section D)
TORAX MEDICAL, INC.
4188 lexington avenue north
shoreview MN
MDR Report Key10199986
MDR Text Key197811429
Report Number3008766073-2020-00093
Device Sequence Number1
Product Code LEI
UDI-Device Identifier00855106005356
UDI-Public00855106005356
Combination Product (y/n)N
PMA/PMN Number
P100049
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type study
Type of Report Initial,Followup,Followup,Followup
Report Date 02/11/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/10/2022
Device Model NumberLXMC15
Device Catalogue NumberLXMC15
Device Lot Number23772
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 06/19/2020
Initial Date FDA Received06/26/2020
Supplement Dates Manufacturer Received12/17/2020
01/19/2021
03/01/2021
Supplement Dates FDA Received01/08/2021
02/11/2021
03/22/2021
Patient Sequence Number1
Patient Age40 YR
-
-